Immunolocalization of Nitric Oxide Synthases at the Postsynaptic Domain of Human and Rat Neuromuscular Junctions - Light and Electron Microscopic Studies

Experimental Neurology

Volumn 148, Issue 1, 1997, Pages 34-44

  Yang, Chih Chao ^a   Alvarez, Renate B ^a   Engel, W King ^a   Haun, Charles K ^a   Askanas, Valerie ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Human; Inducible NOS; Neuromuscular junction; Neuronal NOS; Rat

Indexed keywords

BUNGAROTOXIN; DESMIN; DYSTROPHIN; ISOENZYME; NERVE PROTEIN; NITRIC OXIDE SYNTHASE;

ADOLESCENT; ADULT; ANIMAL; ARTICLE; CHILD; DENERVATION; ENZYME IMMUNOASSAY; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOELECTRON MICROSCOPY; INJURY; MALE; MIDDLE AGED; MUSCULAR DYSTROPHY; MYASTHENIA GRAVIS; NERVE DEGENERATION; NEUROMUSCULAR SYNAPSE; PATHOLOGY; RAT; SCIATIC NERVE; ULTRASTRUCTURE;

ADOLESCENT; ADULT; ANIMALS; BUNGAROTOXINS; CHILD; DENERVATION; DESMIN; DYSTROPHIN; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; ISOENZYMES; MALE; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; MUSCULAR DYSTROPHIES; MYASTHENIA GRAVIS; NERVE TISSUE PROTEINS; NEUROMUSCULAR JUNCTION; NITRIC OXIDE SYNTHASE; RATS; RETROGRADE DEGENERATION; SCIATIC NERVE;

EID: 0031263930     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6663     Document Type: Article

References (46)

1. Akaaboune, M., M. Villanova, B. W. Festoff, et al. 1994. Apolipoprotein E expression at neuromuscular junctions in mouse, rat and human skeletal muscle. FEBS Lett. 351: 246-248.
2. Askanas, V., W. K. Engel, and R. B. Alvarez. 1992. Strong immunoreactivity of β-amyloid precursor protein, including the β-amyloid protein sequence, at human neuromuscular junctions. Neurosci. Lett. 143: 96-100.
3. Askanas, V., R. B. Alvarez, and W. K. Engel. 1993. β-Amyloid precursor epitopes in muscle fibers of inclusion-body myositis. Ann. Neurol. 34: 551-560.
4. Askanas, V., M. Bilak, W. K. Engel, A. Leclerc, and F. Tomé. 1993. Prion protein is strongly immunolocalized at the postsynaptic domain of human normal neuromuscular junctions. Neurosci. Lett. 159: 111-114.
5. Askanas, V., W. K. Engel, M. Bilak, R. B. Alvarez, and D. J. Selkoe. 1994. Twisted tubulofilaments of inclusion-body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau. Am. J. Pathol. 144: 177-187.
6. Askanas, V., E. Sarkozi, R. B. Alvarez, J. McFerrin, W. K. Engel, and T. Siddique. 1996. Superoxide-dismutase-1 (SOD1) gene and protein in vacuolated muscle fibers of sporadic inclusion-body myositis (s-IBM), hereditary inclusion-body myopathy (h-IBM), and cultured human muscle after β-amyloid precursor protein (βAPP) gene transfer. Neurology 46: 487.
7. Beckman, J. S., J. Chen, J. P. Crow, and Y. Z. Ye. 1994. Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. In Progress in Brain Research, Neural Regeneration (F. J. Seil, Ed.), Vol. 103, pp. 371-380. Elsevier, Amsterdam.
8. 1-Antichymotrypsin is strongly immunolocalized at normal human and rat neuromuscular junctions. Synapse 16: 280-283.
9. Bowe, M. A., and J. R. Fallon. 1995. The role of agrin in synapse formation. Annu. Rev. Neurosci. 18: 443-462.
10. Brenman, J. E., D. S. Chao, H. Xia, K. Aldape, and D. S. Bredt. 1995. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in duchenne muscular dystrophy. Cell 82: 743-752.
11. Brenman, J. E., D. S. Chao, S. H. Gee, A. W. McGee, S. E. Craven, D. R. Santillano, Z. Wu, F. Huang, H. Xia, M. F. Peters, S. C. Froehner, and D. S. Bredt. 1996. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell 84: 757-767.
12. Burden, S. J. 1993. Synapse-specific gene expression. TIG 9: 12-16.
13. Chang, W.-J., S. T. Iannaccone, K. S. Lau, B. S. S. Masters, T. J. McCabe, K. McMillan, R. C. Padre, M. J. Spencer, J. G. Tidball, and J. T. Stull. 1996. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc. Natl. Acad. Sci. USA 93: 9142-9147.
14. Conner, E. A., and M. A. Smith. 1994. Retrograde signaling in the formation and maintenance of the neuromuscular junction. J. Neurobiol. 25: 722-739.
15. Crow, J. P., and J. S. Beckman. 1995. The role of peroxynitrite in nitric oxide-mediated toxicity. In Current Topics in Microbiology and Immunology: The Role of Nitric Oxide in Physiology and Pathophysiology (H. Kaprowski and H. Maeda, Eds.), Vol. 196, pp. 57-73. Springer-Verlag, Berlin.
16. Dawson, T. M., and S. H. Snyder. 1994. Gases as biological messengers: Nitric oxide and carbon monoxide in the brain. J. Neurosci. 14: 5147-5159.
17. Engel, W. K. 1967. Muscle biopsies in neuromuscular diseases. Pediat. Clin. N. Am. 14: 963-995.
18. Fallon, J. R., and Z. W. Hall. 1994. Building synapses: Agrin and dystroglycan stick together. TINS 17: 469-173.
19. Förstermann, U., E. I. Closs, J. S. Pollock, M. Nakane, P. Schwarz, I. Gath, and H. Kleinert. 1994. Nitric oxide synthase isozymes: Characterization, purification, molecular cloning, and functions. Hypertension 23: 1121-1131.
20. Frandsen, U., M. Lopez-Figueroa, and Y. Hellsten. 1996. Localization of nitric oxide synthase in human skeletal muscle. Biochem. Biophys. Res. Commun. 227: 88-93.
21. Gath, I., E. I. Closs, U. Gödtel-Armbrust, S. Schmitt, M. Nakane, I. Wessler, and U. Förstermann. 1996. Inducible NO synthase II and neuronal NO synthase I are constitutively expressed in different structures of guinea pig skeletal muscle: Implications for contractile function. FASEB J. 10: 1614-1620.
22. Gorycki, M., and V. Askanas. 1977. Improvements of the technique of electron-microscopy of the cultured cells. Stain Technol. 52: 249-254.
23. Grozdanovic, Z., G. Nakos, G. Dahrmann, B. Mayer, and R. Gossrau. 1995. Species-independent expression of nitric oxide synthase in the sarcolemma region of visceral and somatic straited muscle fibers. Cell Tissue Res. 281: 493-199.
24. Grozdanovic, Z., G. Gosztonyi, and R. Gossrau. 1996. Nitric oxide synthase I (NOS-I) is deficient in the sarcolemma of striated muscle fibers in patients with Duchenne muscular dystrophy, suggesting an association with dystrophin. Acta Histochem. 98: 61-69.
25. Haginoya, K., R. B. Alvarez, W. K. Engel, and V. Askanas. 1997. Light- and electron-microscopic immunolocalization of interleukins 1α, 1β and 6 in vacuolated muscle fibers of sporadic inclusion-body myositis (s-IBM). Neurology 48: 126.
26. Hall, Z. H., and J. R. Sanes. 1993. Synaptic structure and development: The neuromuscular junction. Cell 72/Neuron 10: 99-121.
27. Hecker, M., A. Mülsch, and R. Busse. 1994. Subcellular localization and characterization of neuronal nitric oxide synthase. J. Neurochem. 62: 1524-1529.
28. Hunot, S., F. Boissière, B. Faucheux, B. Brugg, A. Mouatt-Prigent, Y. Agid, and E. C. Hirsch. 1996. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 72: 355-363.
29. Karnovsky M. J., and L. Roots. 1964. A direct-coloring of thiocholine method for cholinesterases. J. Histochem. Cytochem. 12: 219-221.
30. Kobzik, L., M. B. Reid, D. S. Bredt, and J. S. Stamier. 1994. Nitric oxide in skeletal muscle. Nature 372: 546-548.
31. Lee, K. H., M. Y. Baek, K. Y. Moon, W. K. Song, C. H. Chung, D. B. Ha, and M.-S. Kang. 1994. Nitric oxide as a messenger molecule for myoblast fusion. J. Biol. Chem. 269: 14371-14374.
32. Mirabella, M., R. B. Alvarez, M. Bilak, W. K. Engel, and V. Askanas. 1996. Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies. J. Neuropathol. Exp. Neurol. 55: 774-786.
33. Mirabella, M., R. B. Alvarez, W. K. Engel, K. H. Weisgraber, and V. Askanas. 1996. Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion-body myositis and myopathies. Ann. Neurol. 40: 864-872.
34. Nathan, C., and Q.-W. Xie. 1994. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269: 13725-13728.
35. Oliver, L., O. Goureau, Y. Courtois, and M. Vigny. 1996. Accumulation of NO synthase (type-1) at the neuromuscular junctions in adult mice. NeuroReport 7: 924-926.
36. Park, C.-S., R. Park, and G. Krishna. 1996. Constitutive expression and structural diversity of inducible isoform of nitric oxide synthase in human tissues. Life Sci. 59: 219-225.
37. Sarkozi, E., V. Askanas, S. A. Johnson, W. K. Engel, and R. B. Alvarez. 1993. β-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. NeuroReport 4: 815-818.
38. Sarkozi, E., V. Askanas, and W. K. Engel. 1994. Abnormal accumulation of prion protein mRNAin muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy. Am. J. Pathol. 145: 1280-1284.
39. Sealock, R., and S. C. Froehner. 1994. Dystrophin-associated proteins and synapse formation: Is α-dystroglycan the agrin receptor? Cell 77: 617-619.
40. Serdaroglu, P., V. Askanas, and W. K. Engel. 1992. Immunocytochemical localization of ubiquitin at human neuromuscular junctions. Neuropathol. Appl. Neurobiol. 18: 232-236.
41. Thompson, M., L. Becker, D. Bryant, G. Williams, D. Levin, L. Margraf, and B. P. Giroir. 1996. Expression of the inducible nitric oxide synthase gene in diaphragm and skeletal muscle. J. Appl. Physiol. 81: 2415-2420.
42. Wang, T., Z. Xie, and B. Lu. 1995. Nitric oxide mediates activity-dependent synaptic suppression at developing neuromuscular synapses. Nature 374: 262-266.
43. Williams, G., T. Brown, L. Becker, M. Prager, and B. P. Giroir. 1994. Cytokine-induced expression of nitric oxide synthase in C2C12 skeletal muscle myocytes. Am. J. Physiol. 267: 1020-1025.
44. Wu, K., J.-L. Xu, P.-C. Suen, Y.-U. Huang, and H. T. J. Mount. 1996. Nitric oxide increases calcium/calmodulin-dependent phosphorylation of proteins in the postsynaptic density of adult rat cerebral cortex. Mol. Brain Res. 40: 22-26.
45. Yang, C.-C., R. B. Alvarez, W K. Engel, and V. Askanas. 1996. Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis. NeuroReport 8: 153-158.
46. Zacks, S. I., W C. Bauer, and J. M. Blumberg. 1962. The fine structure of myasthenic neuromuscular junction. J. Neuropathol. Exp. Neurol. 21: 335-347.